These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12944069)

  • 21. [Methodology and legitimacy of French clinical trials in primary chemoprevention of cancers. The point of view of the National Federation of French cancer centers].
    Eisinger F; Maraninchi D; Philip T
    Bull Cancer; 1995 Jul; 82 Suppl 3():232s-236s. PubMed ID: 7492838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESMO 2014: new trends in precision medicine.
    Morere JF; Innominato P
    Target Oncol; 2014 Dec; 9(4):293-4. PubMed ID: 25503266
    [No Abstract]   [Full Text] [Related]  

  • 23. Two novel agents, one trial.
    Eur J Cancer; 2006 Sep; 42(14):2195. PubMed ID: 17061315
    [No Abstract]   [Full Text] [Related]  

  • 24. 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.
    Pearson AD; Heenen D; Kearns PR; Goeres A; Marshall LV; Blanc P; Vassal G
    Lancet Oncol; 2018 Mar; 19(3):285-287. PubMed ID: 29508745
    [No Abstract]   [Full Text] [Related]  

  • 25. Addressing the challenge of intergroup studies in oncology: the EORTC experience. European Organisation for Research and Treatment of Cancer.
    Zurlo A; Therasse P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S169-72. PubMed ID: 11858988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regulation of clinical research in European countries].
    Polizzi R
    Ann Ig; 1990; 2(3):181-91. PubMed ID: 1710132
    [No Abstract]   [Full Text] [Related]  

  • 27. Too few older patients in cancer trials: experts say disparity affects research results and care.
    Mitka M
    JAMA; 2003 Jul; 290(1):27-8. PubMed ID: 12837701
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical Trials Directive slows registration of paediatric studies.
    Cannell E
    Lancet Oncol; 2007 Jan; 8(1):10. PubMed ID: 17348116
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Mind the gap' between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical research.
    Kempf E; Bogaerts J; Lacombe D; Liu L
    Eur J Cancer; 2017 Nov; 86():143-149. PubMed ID: 28987771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New drugs in oncology--features of clinical trials for market authorisation and arguments for the rapid implementation of independent clinical trials following approval].
    Ludwig WD; Schott G
    Onkologie; 2013; 36 Suppl 2():17-22. PubMed ID: 23549032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why the EU matters in cancer.
    O'Donnell P
    Eur J Cancer; 2001 Oct; 37(15):1807. PubMed ID: 11601423
    [No Abstract]   [Full Text] [Related]  

  • 32. Geriatric oncology aims for clinical trials.
    Sinha G
    J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
    [No Abstract]   [Full Text] [Related]  

  • 33. Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. Preface.
    Gastl G; Dittrich C
    Onkologie; 2003 Oct; 26 Suppl 6():IX. PubMed ID: 23570176
    [No Abstract]   [Full Text] [Related]  

  • 34. Trials of a cancer doc. Experimental drugs and a 20-year fight with the FDA.
    Brownlee S
    US News World Rep; 1998 Oct; 125(13):28-30, 32, 35. PubMed ID: 10186429
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities.
    Rigaudy P
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i54-59. PubMed ID: 24516214
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in European cross-border cancer research and treatment.
    Gethins M
    J Natl Cancer Inst; 2011 Jun; 103(11):845-6, 852. PubMed ID: 21606437
    [No Abstract]   [Full Text] [Related]  

  • 37. Cancer research funding in Europe low compared with U.S., survey finds.
    Illman J
    J Natl Cancer Inst; 2005 May; 97(10):713-4. PubMed ID: 15900040
    [No Abstract]   [Full Text] [Related]  

  • 38. [Huriet's law in cancerology. Ethical commissions and medical research in Switzerland].
    Alberto P
    Bull Cancer; 1993 Oct; 80(10):890-1. PubMed ID: 8204928
    [No Abstract]   [Full Text] [Related]  

  • 39. Commentary on "European collaboration in trials of new agents for children with cancer" by Ablett et al.
    Smith MA; Anderson BD
    Eur J Cancer; 2004 Aug; 40(12):1893-5. PubMed ID: 15288292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Commission updates rules on clinical trials.
    den Exter A
    Contemp Clin Trials; 2013 Jan; 34(1):173. PubMed ID: 23149215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.